As of November 2024, ACADIA Pharmaceuticals has a market cap of $2.68B. This makes ACADIA Pharmaceuticals the world's 4295th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $4.09B | -20.34% |
2023 | $5.14B | 96.67% |
2022 | $2.61B | -31.79% |
2021 | $3.83B | -56.34% |
2020 | $8.78B | 24.96% |
2019 | $7.02B | 164.56% |
2018 | $2.65B | -46.30% |
2017 | $4.94B | 4.40% |
2016 | $4.73B | -19.10% |
2015 | $5.85B | 12.28% |
2014 | $5.21B | 27.05% |
2013 | $4.10B | 437.42% |
2012 | $763.44M | 330.56% |
2011 | $177.31M | -10.00% |
2010 | $197.02M | -9.09% |
2009 | $216.72M | 46.67% |
2008 | $147.76M | -91.87% |
2007 | $1.82B | 25.94% |
2006 | $1.44B | -10.76% |
2005 | $1.62B | 45.49% |
2004 | $1.11B | - |